Get the weekly note
ETFIQetfiq.com · independent ETF data

Data as of .

GNOM vs IBBQ: which is really different?

GNOM and IBBQ hold 20% of their weight in the same names, and GNOM returned more over the year.

Global X Genomics & Biotechnology ETF and Invesco Nasdaq Biotechnology ETF.

20.9%GNOM in the S&P 500
38.6%IBBQ in the S&P 500
+77.5%GNOM total return, 1 year
+44.6%IBBQ total return, 1 year

ETFIQ Off-Index Score: IBBQ scores higher

How much of it is not the index it is sold as an alternative to?

GNOM 44.5IBBQ 61.70.1, the lowest in this set91.8, the highest

A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed

GNOM79% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
21%79%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 53% of the fund · 52 holdings filed Sep 18, 2026 · Nasdaq-100: 5% in21%79%inoutside the S&P 500active share 98% · top ten 53% of the fund
IBBQ61% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
39%61%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 45% of the fund · 256 holdings filed Sep 19, 2026 · Nasdaq-100: 33% in39%61%in the S&P 500outside the S&P 500active share 99% · top ten 45% of the fund

20% of the two portfolios are the same securities at the same weight.

What they hold in common

By the books each fund has filed, GNOM and IBBQ hold 20% of their money in the same securities at the same weight.

Positions GNOM and IBBQ both hold, largest shared weight first
HoldingGNOMIBBQ
MODERNA INC7.99%4.10%
VERTEX PHARMACEUTICALS INC3.35%7.98%
ILLUMINA INC5.30%2.43%
GILEAD SCIENCES INC1.63%7.89%
GUARDANT HEALTH INC5.78%1.59%
BIOMARIN PHARMACEUTICAL INC3.41%0.83%
BIONTECH SE-ADR2.55%0.75%
TWIST BIOSCIENCE CORP7.40%0.70%
ARROWHEAD PHARMACEUTICALS IN2.59%0.63%
10X GENOMICS INC-CLASS A6.53%0.60%
CARIS LIFE SCIENCES INC2.72%0.57%
PRAXIS PRECISION MEDICINES I2.56%0.56%
Only in each
Only in GNOMOnly in IBBQ
NATERA INC 5.13%Amgen Inc 8.05%
GENSCRIPT BIOTECH CORP 4.29%Regeneron Pharmaceuticals Inc 5.42%
BIO-TECHNE CORP 3.56%Revolution Medicines Inc 2.72%
QIAGEN N.V. 3.13%Alnylam Pharmaceuticals Inc 2.14%
GENEDX HOLDINGS CORP 1.96%Biogen Inc 2.13%
CAREDX INC 1.85%Roivant Sciences Ltd 1.92%
BILLIONTOONE INC CL A 1.58%Argenx SE 1.83%
ASTRAZENECA PLC 1.23%Insmed Inc 1.74%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 18, 2026 and Sep 19, 2026.

Performance, window by window

GNOM and IBBQ over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ.
WindowTotal returnvs the S&P 500vs the Nasdaq-100
GNOMIBBQGNOMIBBQGNOMIBBQ
3 months+27.6%+15.8%+25.4 pts+13.6 pts+30.1 pts+18.3 pts
6 months+56.4%+24.9%+38.4 pts+6.9 pts+32.2 pts+0.7 pts
1 year+77.5%+44.6%+60.9 pts+28.0 pts+55.7 pts+22.8 pts
3 years+59.3%+76.7%−19.1 pts−1.7 pts−38.9 pts−21.5 pts
Since launch+9.8%+42.0%−185.2 pts−51.2 pts−297.4 pts−76.1 pts
Open the live comparison on ETFIQ
GNOM and IBBQ on the same fields, as of Sep 18, 2026. Source: ETFIQ.
GNOM
Global X Genomics & Biotechnology ETF
Holds 52 stocks in genomics and gene editing, 21% of its weight in S&P 500 companies
IBBQ
Invesco Nasdaq Biotechnology ETF
Holds 256 stocks in biotech, 39% of its weight in S&P 500 companies
IssuerGlobal XInvesco
ThemeGenomics and gene editingBiotech
In the S&P 50020.9%38.6%
Active share vs the S&P 50097.6%99.0%
In the Nasdaq-1005.0%33.2%
Holdings52256
Top ten, share of the fund52.7%44.8%
Expense ratio0.50%0.19%
Fee for the differing part0.51%0.19%
Total return, 1 year+77.5%+44.6%
vs the S&P 500+60.9 pts+28.0 pts
vs the Nasdaq-100+55.7 pts+22.8 pts
Below its high−39.6%−5.8%
Net assets$100m$96m

GNOM in plain words

By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 53% of the fund across 52 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +77.5% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 60.9 pts. It sits 39.6% below its all-time high of Feb 8, 2021.

IBBQ in plain words

By weight, 39% of IBBQ's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 45% of the fund across 256 positions, as published by its issuer for Sep 19, 2026. Over the year to Sep 18, 2026 the fund returned +44.6% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 28.0 pts. It sits 5.8% below its all-time high of Aug 19, 2026.

Questions people ask

Do GNOM and IBBQ hold the same stocks?
By their latest filings, 20% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, GNOM or IBBQ?
GNOM has 21% of its weight in S&P 500 names and IBBQ has 39%, so IBBQ differs more from the index.
Which is cheaper, GNOM or IBBQ?
GNOM charges 0.50% a year and IBBQ charges 0.19%, so IBBQ is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

GNOM against IBBQ, ETFIQ, data as of Sep 18, 2026. Every figure is calculated from a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, GNOM against IBBQ, data as of Sep 18, 2026. https://etfiq.com/compare/themes/gnom-vs-ibbq Free to use with attribution; the underlying files are at Open data.

How every figure is computed · Standards and sources